Skip to content

PSYC

Clarify Pharma PLC

Access


ISIN

GB00BMCD8M81

Bid

0.72

Mid

0.77

Ask

0.82

Key Information

Price Change
0.00%
Year High
1.10
Year Low
0.77
Last Trade
21 Apr 23
Market Cap
£2.29M
Par
0.00
Bid
0.72
Mid Price
0.77
Ask
0.82
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
297.2M
Sector
Healthcare

Prices in GBX except for Market Cap in GBP

About Clarify Pharma PLC

Clarify seeks to develop a business concentrating on high potential and fast-growing biotech and life science companies that perform research or produce neuro-pharmaceutical drug development platforms. The focus will be on businesses that advance medicines based on psychedelic substances through rigorous science and clinical trials.

Clarify Pharma PLCAccess

Latest Trades

DateVolumePrice (GBX)Value (GBP)

21 Apr 23

10:39

2,500,0000.8020,000.00

21 Apr 23

10:39

2,500,0000.8020,000.00

18 Apr 23

08:48

2,500,0000.8020,000.00

18 Apr 23

08:48

2,500,0000.8020,000.00

03 Apr 23

12:42

200,0000.811,620.00
View all trades

Latest Announcements

DateTitle

30 May 23

07:00

Clarify Pharma PLC - Full Year Results

24 Nov 22

07:00

Clarify Pharma PLC - Acquisition of Shares

31 Aug 22

07:00

Clarify Pharma PLC - Interim results

30 May 22

16:27

Clarify Pharma PLC - Result of Annual General Meeting

05 May 22

07:00

Clarify Pharma PLC - Full Year Results
View all announcements

Address

Registered Address

9th Floor, 16 Great Queen Street, London, WC2B 5DG, England

Email

nl@nlconsulting.co.uk

Phone

+44 207 183 7407

Contacts

Corporate Adviser

First Sentinel Corporate Finance, 72 Charlotte Street, London , W1T 4QQ, United Kingdom

Registrar

Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS13 8AE, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal